Literature DB >> 14576126

First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

Yoshiaki Kawamura1, Hiromitsu Fujiwara, Noriko Mishima, Yuko Tanaka, Ayako Tanimoto, Shiro Ikawa, Youko Itoh, Takayuki Ezaki.   

Abstract

Three isolates of Streptococcus agalactiae highly resistant to multiple fluoroquinolones were isolated in Japan. Compared with susceptible strains of S. agalactiae, these quinolone-resistant strains had double point mutations within the quinolone resistance-determining regions of gyrA and parC; Ser-81 was changed to Leu (TCA --> TTA) in the amino acid sequence deduced from gyrA, and Ser-79 was changed to Phe (TCC --> TTC) in the amino acid sequence deduced from parC. Comparative sequence analysis revealed the possibility of gene transfer between S. agalactiae and another beta-hemolytic streptococcus, Streptococcus difficile.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576126      PMCID: PMC253773          DOI: 10.1128/AAC.47.11.3605-3609.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  In vitro activity of gemifloxacin compared with other antimicrobial agents against recent clinical isolates of streptococci.

Authors:  M Ieven; W Goossens; S De Wit; H Goossens
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

2.  Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)).

Authors:  Svea Sachse; Peter Seidel; Dieter Gerlach; Elisabeth Günther; Jürgen Rödel; Eberhard Straube; Karl-Hermann Schmidt
Journal:  FEMS Immunol Med Microbiol       Date:  2002-10-11

3.  Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

Authors:  Angela B Brueggemann; Stacy L Coffman; Paul Rhomberg; Holly Huynh; Laurel Almer; Angela Nilius; Robert Flamm; Gary V Doern
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

4.  Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan.

Authors:  K Matsubara; Y Nishiyama; K Katayama; G Yamamoto; M Sugiyama; T Murai; K Baba
Journal:  J Antimicrob Chemother       Date:  2001-10       Impact factor: 5.790

5.  Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Authors:  D R Murdoch; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.

Authors:  L M Weigel; G J Anderson; R R Facklam; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

7.  Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance.

Authors:  S S Yan; M L Fox; S M Holland; F Stock; V J Gill; D P Fedorko
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan.

Authors:  Shin-Ichi Yokota; Kiyoshi Sato; Osamu Kuwahara; Satoshi Habadera; Naoyuki Tsukamoto; Hironori Ohuchi; Hirotsugu Akizawa; Tetsuo Himi; Nobuhiro Fujii
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 9.  Fluoroquinolone resistance among Gram-positive cocci.

Authors:  David C Hooper
Journal:  Lancet Infect Dis       Date:  2002-09       Impact factor: 25.071

10.  Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.

Authors:  J H Jorgensen; L M Weigel; M J Ferraro; J M Swenson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

View more
  27 in total

1.  First molecular characterization of fluoroquinolone resistance in Aerococcus spp.

Authors:  Vincent Cattoir; Alfred Kobal; Patrick Legrand
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  First characterization of fluoroquinolone resistance in Streptococcus suis.

Authors:  Jose Antonio Escudero; Alvaro San Millan; Ana Catalan; Adela G de la Campa; Estefania Rivero; Gema Lopez; Lucas Dominguez; Miguel Angel Moreno; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Kouji Kimura; Kiyoko Tamai; Hideji Yanagisawa; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

4.  Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.

Authors:  G Piccinelli; F Gargiulo; S Corbellini; G Ravizzola; C Bonfanti; A Caruso; M A De Francesco
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

5.  Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.

Authors:  Constantin Hays; Mathilde Louis; Céline Plainvert; Nicolas Dmytruk; Gérald Touak; Patrick Trieu-Cuot; Claire Poyart; Asmaa Tazi
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

6.  High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.

Authors:  Hui Wang; Chunjiang Zhao; Wenqiang He; Feifei Zhang; Liyan Zhang; Bin Cao; Ziyong Sun; Yingchun Xu; Qing Yang; Yaning Mei; Bijie Hu; Yunzhuo Chu; Kang Liao; Yunsong Yu; Zhidong Hu; Yuxing Ni
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

7.  Characterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates.

Authors:  Hirotsugu Banno; Kouji Kimura; Yosuke Tanaka; Hiromitsu Kitanaka; Wanchun Jin; Jun-ichi Wachino; Keiko Yamada; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

8.  Molecular characterization of acquired enrofloxacin resistance in Mycoplasma synoviae field isolates.

Authors:  I Lysnyansky; I Gerchman; I Mikula; F Gobbo; S Catania; S Levisohn
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

9.  Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan.

Authors:  Hsiu-Mei Wu; Rajendra Prasad Janapatla; Yueh-Ren Ho; Kuei-Hsiang Hung; Chi-Wen Wu; Jing-Jou Yan; Jiunn-Jong Wu
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

10.  Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis.

Authors:  Asmaa Tazi; Thomas Gueudet; Emanuelle Varon; Liliane Gilly; Patrick Trieu-Cuot; Claire Poyart
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.